This week's Fierce Biotech is brought to you by Aldevron. Trouble viewing? Click here.
Aldevron CRISPR-associated nucleases are being used in multiple clinical trials.
When your goal is to develop novel therapies that will impact people's lives, you want to move quickly and confidently. Many vendors offer research-grade CRISPR-associated nucleases. But, these are not applicable to clinical programs due to construct design and quality grade. Changing products late in your development process can lead to rework and costly delays.
Selecting a partner who can grow with you, both in scale and quality, can help avoid this common pitfall. Aldevron offers readily available, in-stock products, including CRISPR-associated nucleases, at both research grade (RG) and cGMP grade to help you advance from research to clinical trials and beyond.
Download to discover:
Immediately available research grade & cGMP Cas nucleases
SpyFi Cas9 & wt knockout efficiency
Reduction of off-target effects with SpyFi Cas9 Nuclease
Efficient TCR knockout with SpCas9 and SpyFi Cas9 Nuclease
Questions?
Want to reach 137,000+ Fierce Biotech subscribers with your own message? Contact aalcover@questex.com or call 202-824-5074.
You are currently subscribed as newsletter@newslettercollector.com. If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe. Refer to our Privacy Policy.
Questex, LLC 685 3rd Avenue, 21st Floor New York, NY 10017
